The disclosure relates to various medical devices, systems and methods of use. Particularly, to a valve device, namely, a clip that is implanted into the valve by positioning the clip over a commissure to partially or completely close an interleaflet triangle and/or provide a docking site for further procedures.
As shown in
At the center of the free edges, there is the nodule of Arantius 22, which is a small fibrous bulge. As would be understood, the free edges (or rims) of each of the cusps 18 are thicker than the cusp body. As a result, during valve closure, the overlap of these rims of adjacent cusps 18 serve to increase the valve support. When the valve is closed, each of the three valve cusps contain a sinus 24 called the “sinus of Valsalva” or “aortic sinus.” The sinuses of Valsalva 24 are outpouching aortic wall structures that are demarcated by the insertion of each cusp. The width of the sinuses 24 is more than the left ventricular outflow tract and of the ascending and when the valve opens, the leaflets 18 fall back into their sinuses 24.
The body of each leaflet 18 is thin and pliable but has a core of fibrous tissue with endothelial linings on its arterial and ventricular sides. During systole, or the phase of ventricular contraction of the cardiac cycle, the pressure in the left ventricle is increased and the aortic valve leaflets 18 are pushed apart and they fall back into their respective sinuses 24, allowing ejection of blood into the aortic root with no impediment on coronary flow. During diastole, or the relaxation phase of the ventricle, the pressure in the ventricle drops below that in the aortic root and the aortic valve leaflets 18 close, thereby preventing regurgitation of the blood into the left ventricle. In a normal aortic valve, the adjacent cusps 18 coapt by at least 2 mm (coaptation height) to ensure valve competence (normal coaptation height ranges from 2-6 mm). There are multiple other parameters that describe cusp 18 anatomy and function including geometric height, effective height, and commissure height.
The normal anatomy of the aortic valve 10 is tricuspid, meaning it has three cusps or leaflets 18, but a common cardiac valvular anomaly is a bicuspid aortic valve (with two leaflets), occurring in 1-2% of the general population. A bicuspid aortic valve results from fusion of aortic valve leaflets and occurs most commonly (=80%) between the right coronary and left coronary leaflets with secondary association with future complications such as insufficiency and/or stenosis.
The interleaflet triangles (also known as subcommisural triangles) 16 mentioned above are important in the normal physiology and hemodynamics of the aortic valve and represent important interrelationships between the aortic sinuses 24, the leaflets 18, and supporting left ventricular structures. The 3 interleaflet triangles 16 are delineated superiorly by the commissures 20, laterally by the attachment of the two adjacent leaflets 18 to the annulus and the left ventricular wall, and inferiorly by basal annulus 14.
There are two typical forms of valve malfunction (which can exhibit themselves separately or in combination in patients): (1) insufficiency (leakage of the valve); and (2) stenosis (narrowing of the valve).
Aortic valve insufficiency (AI) or regurgitation is a condition in which the valve does not close properly, leading to blood flowing backwards in the heart (back into the left ventricle) during diastole instead of pumping out to the body organs. The heart compensates by pumping harder, which, over time, can lead to weakening of the heart muscle and ultimately heart failure.
The prevalence of AI increases with advancing age, and the prevalence of moderate or severe AI has been estimated to be 1.6% of individuals 65 years. AI can result from different pathophysiologic mechanisms, including a dilated aortic annulus, single cusp prolapse in tricuspid aortic valves, or conjoined cusp prolapse in bicuspid aortic valves. The dilated aortic annulus results in a sagging of the belly of the cusps resulting in lack of central cusp apposition.
In patients with chronic AI, the degree of sino-tubular junction and ventriculo-aortic junction dilatation correlates with the severity of AI by preventing adequate cusp coaptation.
Conventional treatment for such a condition is surgery with replacement of the aortic valve using either a prosthetic mechanical valve or prosthetic tissue valve. Disadvantages of aortic valve replacement include (1) possible late prosthetic valve dysfunction secondary to structural failure, (2) bacterial infection of the prosthesis, and (3) the need to keep the patient on blood thinners.
One alternative solution has been the development of aortic valve repair methods to restore normal function of the aortic valve (instead of replacement).
For example, one known aortic valve repair procedure is the reduction annuloplasty, which, as shown in
In a bicuspid aortic valve, regurgitation results from the prolapse of the conjoint cusp. Surgical repair in these cases include resection of the redundant free margin in the central fused raphe portion in addition to closure of the two subcommissural triangles as described above. In cusp prolapse in a tricuspid valve, AI is caused by the prolapse of one or more cusps. This is repaired surgically by resection to shorten the free margin to meet the other cusps triangular resection in the center of the cusp with re-approximation of the cut edges of the cusp with interrupted 6-0 polypropylene sutures and closure of the three subcommissural triangles as previously described.
Recently, a less invasive procedure has been introduced to treat the narrowing of the aortic valve (aortic valve stenosis): transcatheter aortic valve implantation (TAVI). TAVI has proved to be as effective, and safer, than the traditional surgical replacement.
However, in the case of pure native AI, TAVI is not considered a safe alternative for surgical replacement or repair because of the absence of significant leaflet or annular calcifications in most cases of pure AI. The positioning of the prosthesis in TAVI in the precisely correct position depends on anchoring on the calcifications universally found in cases of aortic valve stenosis. Thus, TAVI for patients with pure AI carries potential risks including (1) malpositioning due to inadequate sealing, (2) valve embolization, and (3) significant leak around the valve (paravalvular regurgitation). Oversizing of the TAVI prosthesis in an attempt to better anchor and seal the device also involves a risk of valve dislocation, conduction disorders, and annulus rupture.
Even though standard surgical repair of the valve is an established effective method, it is a very invasive method with several risks including death, stroke, bleeding, infection, heart rhythm problems, blood clots, significant discomfort, an extended hospital stay, and prolonged recovery. There is a need in the art for an devices and related non-invasive or less-invasive methods for valve repair in the treatment of insufficiency.
Described herein are various implementations relating to devices, systems and methods for an improved device and related non-invasive or less-invasive methods for valve repair in the treatment of insufficiency. Certain implementations are for aortic valve repair in the treatment of aortic insufficiency.
In Example 1, a valve clamping device, the device comprising a first arm comprising at least one first string attachment structure operably coupled to the first arm and a first tissue contact structure operably coupled to the first arm at or near the distal end of the first arm a second arm operably coupled at a proximal end to a proximal end of the first arm, the second arm comprising at least one second string attachment structure operably coupled to the second arm and a second tissue contact structure operably coupled to the second arm at or near the distal end of the second arm, a proximal attachment mechanism operably coupled to the proximal ends of the first and second arms and an arm coupling device attached to the first and second arms.
In Example 2, the valve clamping device of Example 1, wherein the arm coupling device comprises a tension mechanism or a locking mechanism.
In Example 3, the valve clamping device of Example 2, wherein the arm coupling device comprises the tension mechanism, wherein the tension mechanism is a tension spring.
In Example 4, the valve clamping device of Example 2, wherein the arm coupling device comprises the locking mechanism, wherein the locking mechanism comprises a locking rod coupled at a first end to the first arm and at a second end to the second arm and an attachment structure associated with the locking rod.
In Example 5, the valve clamping device of Example 4, further comprising an elongate actuation structure coupleable to the attachment structure.
In Example 6, the valve clamping device of Example 1, further comprising a first actuation string disposed through the at least one first string attachment structure and a second actuation string disposed through the at least one second string attachment structure.
In Example 7, the valve clamping device of Example 1, wherein the first and second arms are movable in relation to each other between an open configuration and a closed configuration in which the first and second tissue contact structures are disposed in close proximity.
In Example 8, the valve clamping device of Example 1, wherein the first and second tissue contact structures comprise attachment enhancement mechanisms disposed thereon.
In Example 9, the valve clamping device of Example 8, wherein the attachment enhancement mechanisms comprise spikes.
In Example 10, the valve clamping device of Example 1, wherein the proximal attachment mechanism is coupleable to a delivery catheter.
In Example 11, the valve clamping device of Example 1, wherein the device is sized to be positionable through a delivery sheath.
In Example 12, a valve clamping device, comprising a plurality of arms having proximal and distal ends a plurality of blades or paddles disposed at the distal ends of the plurality of arms a plurality of rings attached to the plurality of arms and a proximal attachment mechanism.
In Example 13, the valve clamping device of Example 12, wherein the proximal attachment mechanism is a knob configured to be attached to a delivery device used in conjunction with the valve clamping device.
In Example 14, the valve clamping device of Example 13, wherein the knob is threaded.
In Example 15, the valve clamping device of Example 12, further comprising a tension component configured for tensioned and untensioned states.
In Example 16, the valve clamping device of Example 12, further comprising a central rod defining a rod lumen.
In Example 17, the valve clamping device of Example 16, wherein the rod lumen is sized to accommodate a guide wire.
In Example 18, a valve clamping device, the device comprising a first arm comprising at least one first string attachment structure operably coupled to the first arm and a first tissue contact structure operably coupled to the first arm at or near the distal end of the first arm a second arm operably coupled at a proximal end to a proximal end of the first arm, the second arm comprising at least one second string attachment structure operably coupled to the second arm and a second tissue contact structure operably coupled to the second arm at or near the distal end of the second arm.
In Example 19, the valve clamping device of Example 18, further comprising a proximal attachment mechanism operably coupled to the proximal ends of the first and second arms.
In Example 20, the valve clamping device of Example 18, further comprising an arm coupling device attached to the first and second arms.
In Example 21 a valve device comprising a first arm, a first tissue contact coupled to the first arm at a distal end of the first arm, a second arm, a second tissue contact couple to the second arm at a distal end of the second arm, an arm coupling device couple to a proximal end of the first arm and the second arm, a central rod extending from the arm coupling device, and at least one extension extending from the central rod.
Example 22 relates to the valve device of any of Examples 21 and 23-31, wherein the valve device forms an anchor.
Example 23 relates to the valve device of any of Examples 21-22 and 24-31, wherein the at least one extension comprises at least two flexible curved extensions configured to support leaflets on either side of the central rod.
Example 24 relates to the valve device of any of Examples 21-23 and 25-31, wherein the at least one extension is configured to fill an interleaflet triangle.
Example 25 relates to the valve device of any of Examples 21-24 and 26-31, wherein the at least one extension comprises a plurality of protrusions about the central rod.
Example 26 relates to the valve device of any of Examples 21-25 and 27-31, wherein the at least one extension comprises two flared protrusions on opposing sides of a body of the central rod.
Example 27 relates to the valve device of any of Examples 21-26 and 28-31, wherein the at least one extension comprises two flared protrusions extending from a distal end of the central rod.
Example 28 relates to the valve device of any of Examples 21-27 and 29-31, wherein the at least one extension comprises two or more extensions branched diagonally from a body of the central rod.
Example 29 relates to the valve device of any of Examples 21-28 and 30-31, wherein the at least one extension comprises a four or more extensions extending from a body of the central rod at various intervals.
Example 30 relates to the valve device of any of Examples 21-29 and 31, wherein the central rod is configured to occupy a subcomissural space.
Example 31 relates to the valve device of any of Examples 21-30, wherein the central rod defines a lumen for insertion of a wire.
In Example 32 a valve device comprising a first arm and a second arm configured to hold the valve device in place at an interleaflet triangle, a proximal attachment mechanism at a proximal end of the first arm and the second arm, a central rod extending from the proximal attachment mechanism, and at least two extensions extending from the central rod, the at least two extensions configured to support valve leaflet.
Example 33 relates to the valve device of any of Examples 32 and 34-35, wherein the valve device is an anchor for transcatheter valve implantation.
Example 34 relates to the valve device of any of Examples 32-33 and 35, wherein the first arm and second arm are paired on one side of the central rod.
Example 35 relates to the valve device of any of Examples 32-34, further comprising an arm groove wherein the first arm and second arm are slidable along the arm groove for actuation between deployed and undeployed positions.
In Example 36 a method for treating a valve comprising inserting at least one valve device into a patient through a catheter, the at least one valve device comprising: a first arm and a second arm configured to hold the valve device in place at an interleaflet triangle; a proximal attachment mechanism at a proximal end of the first arm and the second arm; a central rod extending from the proximal attachment mechanism; and at least two extensions extending from the central rod, the at least two extensions configured to support valve leaflet, and deploying the at least one valve device by attaching the first arm and the second arm to at least one valve leaflet and extending the central rod into the subcommissural space.
Example 37 relates to the method of any of Examples 36 and 38-40, wherein the patient has valve insufficiency.
Example 38 relates to the method of any of Examples 36-37 and 39-40, wherein the patient is undergoing transcatheter aortic valve implantation.
Example 39 relates to the method of any of Examples 36-38 and 40, wherein the valve is an aortic valve.
Example 40 relates to the method of any of Examples 36-39, wherein the first arm and second arm are paired on one side of the central rod, and the first arm and second arm are slidable along an arm groove for actuation between deployed and undeployed positions.
While multiple embodiments are disclosed, still other embodiments of the disclosure will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. As will be realized, the disclosure is capable of modifications in various obvious aspects, all without departing from the spirit and scope of the disclosure. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
The various implementations herein relate to one or more clip, clamping, docking devices for use in a valve (such as, for example, the aortic valve) to address valvular malfunction. As would be appreciated, the clips, docking, and clamping devices described herein may be used in a variety of valves with insufficiency, including the aortic valve and venous valves, including those in the deep veins of the lower extremities. According to certain implementations, these clips or clamping devices can be implanted in a minimally invasive manner using a catheter, guide wire or the like. These various implementations serve as a repair mechanism for a leaky valve (such as an aortic valve) as a result of valve insufficiency or regurgitation and/or as anchors for future transcutaneous valve implantation. In use according to certain implementations, each clip is implanted into the valve by positioning the clip over a commissure to partially or completely close an interleaflet triangle. In most cases, three clips are used, with each clip being positioned over one of the three commissures.
Unlike the system discussed above which is disclosed in U.S. Published Application 2004/0199183, no separate grasper tool is required for deployment of the fastening device. Instead, the various implementations described herein relate to deployable fastening or clip devices that can be implanted without the need for a grasper device or any kind of separate device with clamping components.
The various implementations herein provide less invasive methods and systems for repair of valves and treatment of valvular insufficiency or regurgitation. In certain implementations, the clip implementations herein induce reshaping of the three interleaflet triangles (or subcommissural triangles) of a semilunar valve (such as the aortic valve, for example). The procedures performed using the various clip implementations herein can also be described as a percutaneous subcommissural annuloplasty, which consists of constriction of the interleaflet triangles of the aortic valve. Further, the various clip implementations can also be used to adjust the interleaflet triangle by closing it at a prespecified height. This adjustment can restore the coaptation of the three leaflets of the valve, thereby decreasing regurgitation.
One implementation of a clip 40 or clamping device 40 is depicted in
In addition, the clip 40 of these implementations and others has a tension component 50 disposed between and attached to each of the arms 42A, 42B such that when the tension component 50 is in its untensioned state, the two arms 42A, 42B are disposed in their clamped or closed configuration as best shown in
In accordance with some implementations, the proximal attachment mechanism 48 can be a knob 48 that is attached to any delivery device used in conjunction with the clip 40. The knob 48 can be attached in a threaded manner or alternatively any known manner. If a threaded mechanism is used, the clip 40 can be secured to the catheter or other delivery device by rotating such proximal attachment mechanism 48 clockwise, and the clip 40 can be removed by rotating the device in the counterclockwise direction. In a further alternative, the attachment mechanism 48 can be any known mechanism for attachment to a delivery device.
The arms 42A, 42B can be plates or wires of varying width or diameter. Alternatively, the arms 42A, 42B can have any known shape or configuration. In addition, the arms 42A, 42B can vary in length depending on the anatomical and functional characteristics of the target valve. In various implementations, the arms 42A, 42B, and alternatively the entire clip 40, can be covered in a polymeric material such as PTFE. Alternatively, the material can be any known material that promotes the endothelization and covering of the device 40 with body tissue.
The arms 42A, 42B can be made of any known shape memory material. For example, in certain implementations the arms 42A, 42B can be made of nitinol. Alternatively, the arms 42A, 42B can be made of another metal such as Elgiloy, Phynox, titanium, a titanium alloy, or a stainless steel alloy. In a further alternative, any known shape memory metal or other material can be used. Regardless of the material, according to certain implementations, the material should provide shape memory and sufficient recoil force to hold two adjacent leaflets together in an aortic valve.
Certain components of the device 40, such as the central rod 92, extension 298, and clip arms 42, or all components of the device 40 may be covered in a synthetic material, such as polytetrafluoroethylene (PTFE), polyester (Dacron), or other material to promote the endothelization and covering with body tissue. In these and other implementations, the synthetic material covering the metal (especially on the central rod 92 and extension 298 parts of the device 40) may serve as a surface that would increase the interaction or adherence of the docking device 40 to both the native tissue (wall of aortic root and annulus) on one side and the TAVI device on the other side. In further implementations, the synthetic material covering the metal may function as a medium to create a tight seal between the docking device 40, native tissue, and the TAVI device.
As would be understood, the docking device/clip 40 may have a final passive shape dictated by the memory shape of the material and an enforced shape that straightens the device/clip 40 inside a delivery catheter to facilitate its introduction into the body.
The blades or paddles 44A, 44B are configured to be the contact points for the valvular tissue. More specifically, the paddles 44A, 44B are disposed at the distal end of the arms 42A, 42B such that when the arms 42A, 42B are in the clamped configuration, the paddles 44A, 44B are urged together, thereby urging the tissue of the two adjacent leaflets together such that the leaflet tissue is clamped between the two paddles 44A, 44B.
The paddles 44A, 44B are configured to enhance contact with and attachment to the leaflet tissue. That is, the paddles 44A, 44B can be circular, rectangular, square, or any other known shape of any appropriate size. The paddles 44A, 44B, in certain implementations, can be covered with a polymeric material such as PTFE. Further, in certain implementations, the paddles 44A, 44B can have spikes, pins, or needles that are urged into the target leaflet tissue and thereby improve stability of the clip 40 and attachment to the tissue. Such spikes will be discussed in additional detail below.
Any components of any of the subsequent clip implementations can have the same or similar functions and/or features as the components described above with respect to the implementation depicted in
According to certain implementations, the clip 40 is movable between an open configuration and a closed configuration. In this particular exemplary implementation,
As mentioned above, according to certain implementations, each clip can be delivered to the patient's aortic valve via a minimally invasive procedure using a catheter and/or sheath. According to one specific implementation as shown in
In use, when the clip 40 is positioned near the target commissure, the threads 62 can be urged in a proximal direction by a surgeon or other user, thereby urging the arms 42A, 42B apart, resulting in the clip 40 been urged into its open configuration (similar to
In accordance with a further implementation and as shown in
In yet another implementation as depicted in
Further, the rod 84 can have rod attachment rings or mechanisms 88 attached to each of the arms 42A, 42B such that the rod 84 is coupled to the arms 42A, 42B via the rod attachment rings 88. As such, actuation of the locking mechanism 80 by the elongate actuation structure 82 can cause force to be applied to the locking mechanism 80 at the attachment mechanism 86, thereby actuating the mechanism 82 to lock the two arms 42A, 42B in place.
For example, in one specific implementation, the actuation structure 82 can be urged distally to actuate the locking mechanism 80 to lock the two arms 42A, 42B. Further, once the two arms 42A, 42B are locked in place, the actuation structure 82 can be rotated counter-clockwise to detach from the attachment mechanism 86 and then can be retracted proximally out of the body. According to certain implementations, the elongate actuation structure 82 can be a catheter, wire, or any other known structure for use in actuating a mechanism such as the locking mechanism 80.
In use, according to one implementation, advancing the actuation structure 82 causes the locking mechanism 80 to lock or further tighten the two arms 42A, 42B together, while retracting the actuation structure 82 will loosen the locking mechanism 80 and thereby release the arms 42A, 42B. Alternatively, the locking mechanism 80 as shown can be operated in any known fashion. In a further alternative, any known locking or tightening mechanism can be used.
In addition, the clip 40 in this particular implementation as shown in
Any of the other implementations disclosed or contemplated herein can have a locking mechanism similar to the mechanism 80 described above and/or spikes or pins in the paddles similar to the spikes or pins 90 described above.
In yet another implementation as depicted in
In use, any of the known clip implementations and related catheter and/or sheath implementations can be delivered to the target valve via cardiovascular access. More specifically, the clip and delivery device can be delivered via the femoral artery, radial artery, brachial artery, axillary artery, carotid artery, or any other similar artery. Further, in certain implementations, the delivery can be accomplished using visual guidance such as fluoroscopy and/or ultrasound technologies. Further, in certain implementations the delivery can be accomplished via other physical introduction technologies such as via a guide wire.
In contrast to
Finally,
In any of the various implementations described above, the various clip implementations can be used in a variety of ways to treat a malfunctioning valve. For example, a clip can be implanted to prevent the prolapse of one of two adjacent leaflets by attaching the free edge of the prolapse and leaflet to the free edge of the normal leaflet and thus prevent the redundant leaflet from dropping below the margin of normal valve closure. Additionally, a clip can be used to approximate the adjacent leaflets in cases where gaps have formed secondary to dilation of the annulus of the valve. Further, as discussed above, a clip can be positioned adjacent to the commissural line or alternatively at a more central location depending on the anatomical and functional characteristics of the valve. The depth of the clip into the sinuses can vary depending on the anatomical and functional characteristics of the valve. According to further implementations, one or more clips could be placed at varying distances between each other along each specific line of coaptation between two adjacent leaflets. Further, such clips can be placed on any or all of the coaptation lines between the two adjacent leaflets.
According to various implementations, any clip implementation herein can be recaptured after initial implantation and repositioned depending on the anatomical and functional needs before it is fully released by the delivery device. In further implementations, any clip or clips positioned adjacent to the commissural lines can be used as anchors or docking mechanisms to help stabilize the placement of a transcatheter aortic valve implantation device.
In further implementations, the device/clip acts as an anchor or docking mechanism in order to place a percutaneous valve (TAVR) in patients with aortic insufficiency. Patients with aortic insufficiency typically do not have the calcifications on the aortic valve that are necessary for anchoring a TAVR valve, that are typically present in patients with aortic stenosis. The device may be placed as discussed herein and then used to anchor a TAVR valve.
That is, in these implementations, a catheter may be introduced into a vessel, in a minimally invasive manner, as would be understood, to insert a docking device 240 at one or more of the commissures of the aortic valve to serve as an anchor or docking mechanism for transcutaneous aortic valve implantation (TAVI) for treatment of aortic valve insufficiency (AI).
The docking device 240 facilitates the delivery of TAVI bioprosthesis to the appropriate position in patients with AI by creating a solid interacting medium between the bioprosthesis and the native tissue of the aortic root, specifically at the level of annulus and interleaflet triangle.
As will be described further with reference to the figures below, each device consists of two arms, to fixate it in place by grasping on adjacent leaflets at the commissure level, a spacer/central rod positioned in the interleaflet triangle, and extensions from the spacer/central rod that could form an arch of varying length around the annulus of the aortic valve.
Various further implementations, the device 240, shown variously in
In these and other implementations, the extensions 298 extend from the central rod 292. The extensions 298 may be various shapes, flexibilities, and configurations. Optionally the extensions 298 are flexible with a curved shape to support the bore of the leaflets 218 on both sides of the interleaflet triangles 216, shown for example in
Continuing with
The overall size, shape, and dimensions of the device 240 may be specific for each patient and may be determined via a variety of pre-procedural imaging techniques, as would be appreciated, such as echocardiography, CT scan, and MRI.
In various implementations, the device 300 has two side arms 342A, 342B on the same side of the device 300 working together to hold two adjacent valve leaflets 318. The side arms 342A, 342B may be in slidable communication with an arm groove 350 where the arms 342A, 342B, optionally supported by a v-bracket, slide along the groove 350 between deployed and undeployed position. In various implementations, the groove 350 is within the body 348 of the device 300 and the v-bracket 352 slides along the groove 350 to retract and extend the position of the arms 342A, 342B. In the undeployed position,
The two side arms 342A, 342B may be coupled with a V-shaped bracket/rod 352 that may be made of metal that has a memory V-shape in the undeployed position. That is, when the V-shaped rod 352 is extended to the edge of the groove 350 the rod 352 takes its V-shape. When retracted into the groove 350, the deployed positions, the sides of the V-shaped rod 352 are urged together bringing the side arms into close alignment-adjacent to each other and into the body 348 of the device 300. Actuation between undeployed and deployed positions for the side arms 342A, 342B may be accomplished by an active mechanism such as a screw-in mechanism, slidable control, or other method of control embedded in the groove 350 in the center of the device 300 body 348, as would be understood. The rod 352 may be locked in place once in the final deployed position such that the arms 342A, 342B will not move.
Although the disclosure has been described with references to various embodiments, persons skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of this disclosure.
This application is a continuation-in-part application of U.S. application Ser. No. 17/701,931, filed Mar. 23, 2022, and entitled Valve Reshaping Device, System, and Related Methods. This application further claims the benefit under 35 U.S.C. § 119(e) to U.S. Provisional Application 63/428,639, filed Nov. 29, 2022, and entitled Valve Reshaping Device, System, and Related Methods. Each of the above is hereby incorporated herein by reference in its entirety for all purposes.
Number | Date | Country | |
---|---|---|---|
63164701 | Mar 2021 | US | |
63428639 | Nov 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17701931 | Mar 2022 | US |
Child | 18523610 | US |